Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
novel coronavirus inactivated vaccine (Vero cells)
- Development stage
- Unknown
- Lead developer
- Sinopharm
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The novel coronavirus inactivated vaccine (Vero cells) is a type of vaccine designed to protect against COVID-19. It is an inactivated virus vaccine, meaning it contains SARS-CoV-2 viral particles that have been killed and are unable to cause disease. These inactivated viruses are grown in Vero cells, a cell line commonly used for vaccine production. Upon administration, the vaccine introduces these inactivated viral particles to the immune system, which then recognizes them as foreign and mounts an immune response, including the production of antibodies. This prepares the body to defend against future infection by the live SARS-CoV-2 virus. Many formulations of this vaccine also include an adjuvant, such as aluminum hydroxide, to enhance the immune response. Prominent developers and manufacturers of such vaccines include Sinopharm and Sinovac.
- Brand names
- CoronaVacCoviloBBIBP-CorVZhong'aikeweiHayat-Vax
- Other names
- SARS-CoV-2 Vaccine (VeroCell)COVID-19 Vaccine (Vero Cell), InactivatedInactivated SARS-CoV-2 vaccine (Vero cell)
Beyond the preview
Go deeper on novel coronavirus inactivated vaccine (Vero cells).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on novel coronavirus inactivated vaccine (Vero cells).